ALBHF (Alibaba Health Information Technology) 3-Year RORE % : 20.51% (As of Mar. 2026)


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.42
GF Value $0.68
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology 3-Year RORE %?

Alibaba Health Information Technology ALBHF 55 3-Year RORE % is 20.51 as of Mar. 2026. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 72.28% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Alibaba Health Information Technology's 3-Year RORE % for the quarter that ended in Mar. 2026 was 20.51%.

The industry rank for Alibaba Health Information Technology's 3-Year RORE % or its related term are showing as below:

ALBHF's 3-Year RORE % is ranked better than
72.28% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs ALBHF: 20.51

Alibaba Health Information Technology  (OTCPK:ALBHF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Alibaba Health Information Technology 3-Year RORE % Related Terms


Alibaba Health Information Technology 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology 3-Year RORE % Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 28.57 100.00 25.00 20.51

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 40.91 25.00 21.62 20.51

Alibaba Health Information Technology 3-Year RORE % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's 3-Year RORE % falls into.


ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology 3-Year RORE % Calculation

Alibaba Health Information Technology's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.017-0.009 )/( 0.039-0 )
=0.008/0.039
=20.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 20.51 mean?
Alibaba Health Information Technology (ALBHF) has a 3-Year RORE % of 20.51 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alibaba Health Information Technology and its competitors. According to the industry distribution chart, Alibaba Health Information Technology ranks #168 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 27.7%.
Is Alibaba Health Information Technology's 3-Year RORE % too high?
Alibaba Health Information Technology's current 3-Year RORE % is 20.51. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Alibaba Health Information Technology's value of 20.51 is 10417.9% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #168 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's 3-Year RORE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #168 out of 606 companies for 3-Year RORE %. This puts Alibaba Health Information Technology in the upper half of its industry. The industry median 3-Year RORE % is 0.20. Alibaba Health Information Technology's value of 20.51 is 10417.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current 3-Year RORE % of 20.51 is 10417.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current 3-Year RORE % is 20.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.68, compared to a current price of $0.42 — trading 38.2% below its estimated fair value. The current 3-Year RORE % is 20.51 and 10417.9% above the Healthcare Providers & Services industry median of 0.20. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current 3-Year RORE % is 20.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.42 is trading 38.2% below its estimated GF Value™ of $0.68. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • 3-Year RORE %: 20.51
  • GF Value™: $0.68 vs. price of $0.42 (38.2% below fair value)
  • GF Score™: 55/100 with 2 warning signs
  • Industry Position: 10417.9% above the Healthcare Providers & Services median (#168 of 606)

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.68
GF Value